07Jan
DEAL WATCH: End-of-Year Biosimilar Agreements
Following the string of biosimilar agreements announced in early November, a number of additional transactions were announced in early December, bringing 2019 to a roaring close with global biosimilars deals. On December 1, 2019, Luye Pharma Group...
By:
Goodwin
Related
The Tennessee Air Pollution Control Board (“TAPCB”) issued an October 24th Technical Secretary’s ...
Read More >
For the first time in 15 years, the Supreme Judicial Court (“SJC”), Massachusetts’ highest court,...
Read More >
The state of New York adopted a new section of the New York Labor Law in November 2019. Under the i...
Read More >
As 2019 comes to a close, the Occupational Safety and Health Administration (OSHA) remains active bo...
Read More >
The majority of U.S. states have legalized medical marijuana. Yet many of those same states do not h...
Read More >
In today’s edition of Daily Compliance News: 1. Swiss bank ignores compliance officer; pays $10.7M...
Read More >